These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 2494293)

  • 21. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
    Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
    J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte subsets in the granulomatous response produced after inoculation with Mycobacterium leprae-BCG in lepromatous patients.
    Gross A; Weiss E; Tapia FJ; Aranzazu N; Gallinoto ME; Convit J
    Am J Trop Med Hyg; 1988 May; 38(3):608-12. PubMed ID: 2908581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy.
    Palermo ML; Pagliari C; Trindade MA; Yamashitafuji TM; Duarte AJ; Cacere CR; Benard G
    Am J Trop Med Hyg; 2012 May; 86(5):878-83. PubMed ID: 22556091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines.
    Mustafa AS
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
    Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
    J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zosteriform multidermatomal nodules and plaques in a case of lepromatous leprosy: an uncommon presentation.
    Mathachan SR; Sardana K; Ahuja A; Lavania M; Agrawal D
    Trop Doct; 2020 Oct; 50(4):378-380. PubMed ID: 32600120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum Levels of Migration Inhibitory Factor (MIF) and
    Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
    Front Immunol; 2018; 9():246. PubMed ID: 29487601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of IFN-gamma levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18.
    Lopez Roa RI; Guerrero Velásquez C; Alvarado Navarro A; Montoya Buelna M; Garcia Niebla C; Fafutis Morris M
    Int Immunopharmacol; 2008 Dec; 8(13-14):1715-20. PubMed ID: 18708162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread intradermal accumulation of mononuclear leukocytes in lepromatous leprosy patients treated systemically with recombinant interferon gamma.
    Nathan C; Squires K; Griffo W; Levis W; Varghese M; Job CK; Nusrat AR; Sherwin S; Rappoport S; Sanchez E
    J Exp Med; 1990 Nov; 172(5):1509-12. PubMed ID: 2121891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy.
    Schlienger K; Uyemura K; Jullien D; Sieling PA; Rea TH; Linsley PS; Modlin RL
    J Immunol; 1998 Sep; 161(5):2407-13. PubMed ID: 9725237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lepromatous leprosy: An Unusual Presentation.
    Gupta SK; Kaur S; Malhotra V; Arora AK; Sood N; Gupta V
    Indian J Lepr; 2015; 87(1):27-32. PubMed ID: 26591848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients.
    Kaleab B; Ottenoff T; Converse P; Halapi E; Tadesse G; Rottenberg M; Kiessling R
    Eur J Immunol; 1990 Dec; 20(12):2651-9. PubMed ID: 2269329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2.
    Mohagheghpour N; Gelber RH; Larrick JW; Sasaki DT; Brennan PJ; Engleman EG
    J Immunol; 1985 Aug; 135(2):1443-9. PubMed ID: 2989366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of T cell subset pattern among in vitro M. leprae-stimulated blood lymphocytes of leprosy patients.
    Corbeau P; Desforges S; Bach MA
    Acta Leprol; 1989; 7 Suppl 1():171-2. PubMed ID: 2569800
    [No Abstract]   [Full Text] [Related]  

  • 38. The cutaneous infiltrates of leprosy. A transmission electron microscopy study.
    Kaplan G; Van Voorhis WC; Sarno EN; Nogueira N; Cohn ZA
    J Exp Med; 1983 Oct; 158(4):1145-59. PubMed ID: 6352848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant cells lepromatous leprosy. Diffuse dermatitis with exuberant foreign body giant cells in treated lepromatous leprosy.
    Rodríguez G; Arias V
    Biomedica; 2019 Aug; 39(Supl. 2):26-31. PubMed ID: 31529831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cellular architecture of the antimicrobial response network in human leprosy granulomas.
    Ma F; Hughes TK; Teles RMB; Andrade PR; de Andrade Silva BJ; Plazyo O; Tsoi LC; Do T; Wadsworth MH; Oulee A; Ochoa MT; Sarno EN; Iruela-Arispe ML; Klechevsky E; Bryson B; Shalek AK; Bloom BR; Gudjonsson JE; Pellegrini M; Modlin RL
    Nat Immunol; 2021 Jul; 22(7):839-850. PubMed ID: 34168371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.